Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memoryPrabhash Nath Tripathi, Sushant K. Shrivastava, Surya Pratap Singh et al.|Bioorganic Chemistry|2018Cited by 209
Evolving scenario of big data and Artificial Intelligence (AI) in drug discoveryManish Tripathi, Punit Kaur|Molecular Diversity|2021Cited by 135
Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's diseasePiyoosh Sharma, Sushant K. Shrivastava, Avanish Tripathi et al.|European Journal of Medicinal Chemistry|2019Cited by 99
Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's diseaseAvanish Tripathi, Sushant K. Shrivastava, Priyanka Kumari Choubey et al.|European Journal of Medicinal Chemistry|2019Cited by 72
Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer’s diseaseSushant K. Shrivastava, Rakesh K. Srivastava, Saurabh K. Sinha et al.|Bioorganic Chemistry|2018Cited by 57